Newstral
Article
USA today on 2015-07-27 11:42
Teva buys Allergan generic drug firm for $40.5B
Related news
- Israel’s Teva buys Allergan generic drug company for $40.5Breviewtimes.com
- Israel's Teva buys Allergan generic drug company for $40.5BMerced Sun-Star
- Israel's Teva buys Allergen generic drug company for $40.5Bmcall.com
- In Israel's largest acquisition, Teva buys Allergan Generics for $40.5bThe Jerusalem Post (JPost.com)
- Teva buys Allergan for $40.5b.Ynetnews
- Israel’s Teva buys Allergan generic drug company for $40.5 billionpressherald.com
- Israel’s Teva buys Allergan drug company for $40.5 billiontimesofisrael.com
- Allergan generic drug firm bought for $40.5BThe Salt Lake Tribune
- Allergan sells generic drug company to Israel's Teva for $40.5 billionLA Times
- Teva drops bid for Mylan, buys Allergan generic drug company for $40.5 billionpost-gazette.com
- Teva pushes back completion date for proposed $40.5B Allergan dealbizjournals.com
- Teva buys Allergan for $40.5 billionjewishjournal.com
- Israel's Teva Pharmaceutical to buy Allergan's generic pharmaceuticals business for $40.5BTimesDaily.com